Log in to save to my catalogue

Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma

Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_03639045_2020_1755305

Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma

About this item

Full title

Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma

Publisher

England: Taylor & Francis

Journal title

Drug development and industrial pharmacy, 2020-05, Vol.46 (5), p.806-813

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Objective: Glaucoma is a leading cause of irreversible blindness worldwide. Whereas latanoprost is one of the most effective drugs in glaucoma treatment, its eye drops need frequent application leading to lack of patient adherence. This study aimed to develop a patient-friendly niosome-in-gel system for the sustained ocular delivery of latanoprost....

Alternative Titles

Full title

Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1080_03639045_2020_1755305

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_03639045_2020_1755305

Other Identifiers

ISSN

0363-9045

E-ISSN

1520-5762

DOI

10.1080/03639045.2020.1755305

How to access this item